Prevention of drug-induced programmed and unprogrammed cell death by citrus flavonoids

被引:0
|
作者
Ray, Sidhartha D. [1 ]
Zinkovsky, Daniel [1 ]
Bulku, Ellida [1 ]
Patil, Bhimanagouda S. [1 ]
机构
[1] Long Isl Univ, Mol Toxicol Labs, Div Pharmaceut Sci, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA
来源
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell life and cell death in vivo are delicately balanced and linked processes dependent upon several "death" or "survival" signals from inside and outside the cell. These signals are regulated by several vital intracellular events associated with DNA, RNA, caspases, proteins, and ions. Drugs and other chemicals are known to threaten the stability of such key intracellular molecules by causing ion deregulation, oxidative stress, DNA fragmentation and activation of caspases. Citrus flavonoids, such as hesperidin (HES) and rutin (RUT), are known to specifically interfere with such deleterious pathways, minimize macromolecular perturbations, and exhibit their prolific antitoxic properties. This study was designed to investigate whether HES and RUT pre-exposures (1.25g/kg orally for 14 days) have the ability to counteract hepatotoxicity and nephrotoxicity induced by toxic doses of acetaminophen (APAP, 500 mg/kg, ip) and diclofenac (DCLF, 200 mg/kg, po) respectively in vivo. Additional objectives were to determine whether exposure to these flavonoids protect the liver and kidneys from oxidative stress and genomic DNA fragmentation, the prime players responsible for turning on various forms of cell death. Results indicate that HES and RUT pre-exposures showed dramatic prevention of hepato- and nephrotoxicity by minimizing toxicant-induced oxidative stress and genomic DNA fragmentation which are instrumental in orchestrating apoptotic (programmed) and necrotic (unprogrammed) cell deaths in these organs in vivo.
引用
收藏
页码:144 / 160
页数:17
相关论文
共 50 条
  • [31] DRUG-INDUCED PROGRAMMED CELL-DEATH EVALUATED BY FLOW-CYTOMETRY - EXPERIENCE WITH FLUDARABINE AND INTERFERONS IN RESISTANT B-CLL
    STAGNO, F
    IMPERA, S
    ITALIA, P
    CACCIOLA, E
    GUGLIELMO, P
    GIUSTOLISI, R
    CACCIOLA, E
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 800 - 800
  • [32] Programmed cell death: Will it become a factor in cancer prevention?
    Mayer, V
    Ebbesen, P
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (04) : 323 - 329
  • [33] Drug-induced Death of Eosinophils Promises and Pitfalls
    Persson, Carl
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (06) : 605 - 606
  • [34] Drug-induced Sudden Death: A Scoping Review
    Amaro-Hosey, Kristopher
    Castells, Xavier
    Blanco-Silvente, Lidia
    Loma-Osorio, Pablo
    Capella, Dolors
    CURRENT DRUG SAFETY, 2023, 18 (03) : 307 - 317
  • [35] Postmortem diagnosis of drug-induced anaphylactic death
    Palmiere, Cristian
    JOURNAL OF FORENSIC AND LEGAL MEDICINE, 2016, 41 : 28 - 29
  • [36] Drug-induced sudden cardiac death: reply
    Straus, SMJM
    Stricker, BHC
    EUROPEAN HEART JOURNAL, 2005, 26 (17) : 1809 - 1809
  • [37] INHIBITION EFFECT OF CITRUS CNHX1 GENE TO YEAST PROGRAMMED CELL DEATH INDUCED BY NaCL
    Wei Zhen-Lin
    Li Xiang-Yong
    Jiao Chuan-Zhen
    Li Juan
    Rui Yu-Kui
    Shu Huai-Rui
    ADVANCES IN BIOMEDICAL PHOTONICS AND IMAGING, 2008, : 161 - +
  • [38] Drug-Induced Lupus ErythematosusIncidence, Management and Prevention
    Christopher Chang
    M. Eric Gershwin
    Drug Safety, 2011, 34 : 357 - 374
  • [39] Drug-Induced Respiratory DisordersIncidence, Prevention and Management
    Liubov (Louba) Ben-Noun
    Drug Safety, 2000, 23 : 143 - 164
  • [40] Prevention and treatment of drug-induced liver disease
    Speeg, KV
    Bay, MK
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1995, 24 (04) : 1047 - +